Objective: This study was carried out to evaluate the effects of a single pre-operative sub-mucosal injection of dexamethasone after third molar surgery to see the effects on post-operative discomfort.
INTRODUCTION
Third molar surgery (TMS) is probably traumatic and the most commonly performed dentoalveolar surgical procedure in oral-maxillofacial surgery clinics. As operators perform more invasive or difſ cult procedures, there will be an increased amount of trauma to the surgical site as well as the surrounding tissues. 1 The inƀ ammatory process is necessary if healing of traumatic tissue has to occur, but often excessive inƀ ammations lead to unnecessary pain, trismus and swelling. The impact of these symptoms affect the quality of life in the days following surgery 2 . ___________________________________________________ correspondence:
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Injured tissues immediately release local inƀ ammatory mediators, like histamine, that produce vasodilatation leading to extravasations resulting in edema and sensitize the peripheral nocireceptors resulting in hyperalgesia 3 .Trismus is an inƀ ammation of muscle of the mastication with edema preventing ƀ exibility. Although these inƀ ammatory mediators are released immediately after the trauma, these symptoms are not observed immediate after the surgery but rather begin gradually, peaking 1 -3 days after the surgery 4 .
Traditionally, intravenous, intramuscular or oral CS have been advocated for lessening the severity of the above-mentioned symptoms by surgeons 5, 9 .Despite the frequent clinical use of dexamethasone, there are not many reports in the literature stating the effectiveness of sub-mucosal injection of dexamethasone in reducing the post-operative discomfort following the TMS. Effectiveness of pre-operative submucosal dexamethasone remains poorly investigated in reducing the post-operative sequelae of TMS 10, 11 .
METHODS
T his prospective, randomized, control trial was carried out from March 2009 to October 2009 after obtaining approval from the institutional ethical committee. The inclusion criteria were subjects between 20 -41 years of age who were in good general physical health with no clinically signiſ cant and relevant medical history (ASA I & II ). Subjects having at least one partially or fully bony impacted mandibular third molar and who could understand and were willing to take part in the study and likely to comply with all study procedure were included in this study.
The exclusion criteria were subjects who were on antibiotics and or anti-inƀ ammatory drugs within two weeks of the study entry, pregnant or lactating females and subjects with any active medical illness. Subjects were also excluded in whom the surgery lasted more than one hour and for whom the use of non-trial drugs were prescribed during study period.
The base line facial measurement was done by a 3 -0 silk suture by using a modiſ cation of the method describe by Neupert at al 12 and Schultze-Mosgau et al 13 .
Five reference points were used angle of mandible, tragus, alar base, corner of the mouth and soft tissue pogonion. Three measurements were made: the distance from the tragus to the corner of mouth, the tragus to the pogonion and the mandibular angle to the ala of the nose (Figure 1 ). The pre-operative values of these measurements were considered as the baseline facial contour.
The subjects were asked to open the mouth slowly until pain was ſ rst felt. At that point, the distance between the incisors, edge of the maxillary and mandibular anterior teeth (IIO) were measured by a ruler 14 .The same method was used in the 2 nd and 7 th post-operative day.
The study subjects were randomly assigned into two groups: experimental (DXG) or control group (CTG). For randomization, a random-number table was used to generate a block randomization schedule chart specifying the group to which each subject would be assigned upon the ſ rst-come-ſ rst basis. Ampoules with normal saline (NS) and dexamethasone were given to the nurses who were supporting the trial. On the day of surgery, nurses prepared either the test drug (2 ml dexamethasone) or the placebo (2 ml NS) in identical 2 ml syringes according to a random table and documented the same in a chart.
After the surgical preparation of the subjects, lignocaine 2 % with epinephrine 1:2,00,0000 was used as the anesthetic agent to block the inferior alveolar, lingual and long buccal nerve. Dexamethasone 8 mg (2 ml) or NS 2 ml was injected submucosally into the perithird molar regions. All the subjects were operated by the same operator and under similar conditions to minimize operator variability. The surgical procedure was standardized by a 3-cornered ƀ ap followed by a buccal guttering and distal bone cutting with continuous irrigation with sterile NS. Post-operative instructions were given to subjects, including an ice pack for 20 minutes and a pressure pack for 30 minutes over the surgical site to achieve hemostasis. All the subjects were prescribed. Amoxicillin 500 mg capsuler, per oral three times a day for 5 days and Ibuprofen 400 mg tablets, per oral 8 hourly. The subjects were asked to take the ſ rst analgesic post-operatively as soon as the pain reached moderate level and asked to record the time. The subjects were instructed to not to take any other analgesic drugs.
All the subjects were given a 10 cm visual analog scale (VAS) and instructed about the rating. 15 They were asked to enter their pain level, the time at which the analgesic was taken, and the number of tablets taken until the end of the ſ rst post-operative week. They were asked to report to the OPD on the 2 nd and 7 th post-operative days. The maximum interincisal distance and facial contours were measured on these appointments by the same examiner who had assessed them pre-operatively. The technique and reference points used for these measurements were the same as those based in the pre-operative assessment. The evaluation of trismus and facial edema was recorded as the differences between pre-operative (baseline) and post-operative values.
All the demographic details, base line data and postoperative data were recorded in the case report form over the course of the study. All the data were entered into the spreadsheet (excel, Microsoft) and Chi-square test, Mann-Whitney U test, t student's paired and unpaired t test, and ſ sher exact test were used for analysis of the data.
RESULTS
Forty subjects aged between 20 to 41 years were selected on the basis of inclusion and exclusion criteria. Twenty-four subjects were enrolled in the DXG group and 16 subjects in the CTG group. Ten subjects were excluded from the study. Three had an operating time exceeding an hour, two had been taking analgesics other than prescribed, three were lost for follow-up and two subjects did not complete the questionnaire properly. Data from 30 subjects were included in the study and analysed. The descriptive statistics, demographic and pre-operative variables are summarized in Tables 1. Table 2 and 3 show the Mean and Standard Deviation (SD) of the absolute difference between post-operative (with 2 nd and 7 th day) and pre-operative measures, in relation with the groups.
Swelling
On the second postoperative day, although there was an average increase in facial swelling in both groups the Mann-Whitney U test analysis showed a statistically very highly signiſ cant difference between the two groups (P < 0.001) ( Table 2) .
On the seventh post-operative day, facial swelling in the DXG group was almost same as that of the CTG. There was no statistically signiſ cant difference between the two groups (P = 0.088) ( Table 3 ). It was observed that facial contour by the seventh day post-operatively returned to normal in both the groups. (Figure 2 
Trismus
On the second post-operative day, there was a decrease in the IIO in both the DXG and the CTG compared to the pre-operative measurements. However, the difference between the two groups was signiſ cant (P = 0.044) ( Table 3) . On the seventh post-operative day, the reduction in mouth opening was limited in both the DXG and the CTG groups. No signiſ cant differences in the amount of IIO were noted between the two groups (p = 0.318).
We observed that nearly all subjects regained preoperative IIO after TMS on Day 7 ( Figure 3) . 
Pain and analgesia
The exact time of the ſ rst analgesic taken after the TMS was statistically signiſ cant between the DXG and the CTG groups (Table 4) . The duration of analgesia was 181.58 ± 25.93 minutes in the DXG group while it was 118.09 ± 17.33 minutes in the CTG group, which was statistically signiſ cant (P < 0.0001). Table 3 shows that the number of analgesics received by the subjects of the DXG group (9.21 ± 2.64) was almost the same as that of the CTG group (10.82 ± 2.75), and that it was statistically similar between the groups (p = 0.124). The VAS score for pain assessment showed progressive reduction in pain intensity from the ſ rst to the seventh post-operative day in both the groups (Figure 4 ). Although the total VAS scores (VAS1-7) showed a slight difference between the DXG (5.47± 2.74) and CTG groups (6.09±2.02), it was again statistically not signiſ cant (p = 5.21) (Figure 4 ). 
DISCUSSION
Dental extraction is one of the most frequently performed surgical procedures in dental practice. But only teeth with fully-formed roots and bony impaction (usually the mandibular third molars) are more difſ cult to extract than those with partially-formed or no roots, requiring a more invasive surgery. It is reasonable to infer that more invasive surgery may lead to a greater inƀ ammatory response, further justifying the use of CS only in TMS rather than in routine dental surgery 16 .
Based on pathophysiologic rationale, administering CS may be considered risky by some. However, multiple studies have shown the therapeutic safety of shortterm CS exposures 17 .Based on pathophysiologic and reported literature, the investigators advocate the perioperative use of CS to limit predictable side effects and symptoms associated with only TMS rather than in routine dental extraction.
There are ample studies on perioperative use of CS in oral surgery, 18, 25 but to the best of our knowledge, only two studies have been reported on submucosal administration 10, 11 . It has been shown in various studies that preoperative CS produces a signiſ cant result because the anti-inƀ ammatory mediators are released immediately after the surgical trauma and CS takes 3 -4 hours to act 26 .However, in a typical practice setting, submucosal administering of CS three hours before surgery is usually not convenient. So we preferred submucosal injection of 8 mg dexamethasone as local anesthesia injections just before surgical procedure, which prolong the duration of absorption leading to a maximum concentration at the site of action and a minimum systemic absorption due to the lack of the ſ rst-pass effect by the use of this route 27 .Hence, in this study a single dose pre-operative submucosal dexamethasone was used.
Various studies have shown a signiſ cant decrease of the post-operative swelling in patients who were given a single dose CS immediately before surgery. Markovic A et al 28 reported that IM 4 mg dexamethasone signiſ cantly decreases the post-operative swelling and trismus whereas Neupert et al 12 did not ſ nd any beneſ t after the same administration. This may be a sub-therapeutic dosage. The effect of a submucosal injection of dexamethasone on reduction of edema on the second post-operative day has been shown in previous studies 10, 11 . Our study showed a similar result on the second post-operative day, when maximum facial swelling was expected. However, the effect on reduction of edema on the seventh post-operative day is variable. However, in our study, we have not found any difference between the groups on the seventh post-operative day. This could be due to the fact that the swelling of the face usually resolves after a week of surgery 4 .Also, the half-life of dexamethasone is 36 hours and it suppresses the accumulation of leukocytes at the site of the inƀ ammation and plasma exudation only up to the second post-operative day but not up to the seventh post operative day.
Like some previous reports do, our study showed a signiſ cant improvement in mouth opening on the second post-operative day. Graziani et al 10 reported that endoalveolar applications of dexamethasone powder signiſ cantly reduce the post-operative trismus at both the second and seventh days. But surprisingly, submucosal injection of dexamethasone did not reduce trismus compared with the control group in his study. This may due to the measuring device used by different authors and individual operators may differ in the extent to which they insist on the patient opening his or her mouth widely. Ideally, mouth opening is measured by asking the patient to open the mouth slowly until pain is ſ rst felt. Mouth opening depends on the age of patient, vertical overlap of the central incisors or open bite 14 .
Our study supports the meta-analysis by Markiewecz et al and others who found that a subject receiving CS had a signiſ cantly less trismus than the controls on the second post-operative day. On the seventh postoperative day, nearly all patients gain their pre-operative IIO 28 .Logically, we accepted the Peterson statement that trismus is as a result of inƀ ammation involving several muscles of mastication and directly related to swelling 4 .Hence, we got signiſ cantly less trismus in the DXG group when compared with the CTG on the second post-operative day but not on the seventh postoperative day.
Although some reduction of post-operative pain generally accompanies a reduction of edema and trismus, CS alone do not seem to have a signiſ cant analgesic effect 23, 26 .However, it has been reported that steroids reduce the number of analgesic tablets required after surgery 6, 21 A meta-analysis of six trials by Markiewicz et al found that CS treatment had marginally signiſ cant less pain than the control group in the early post-operative days 28 .We found a difference in pain perception between the groups but with no statistical signiſ cance. Dexamethasone prolongs the duration of action of local anaesthesia 29, 30 . However, the mechanism of the prolongation of duration of block of lidocaine from dexamethasone is unclear. It has been postulated that CS causes vasoconstriction on topical application so it induces vasoconstriction in the perineurium. It is also stated that the CS increases tissue pH that results in an increase in the fraction of the drug in an unionized state, resulting in better penetration of the nerve by the drug. 30 In our study, there is a signiſ cant difference between the test and control groups with regard to the time of the ſ rst analgesic taken after the surgery which means there is a signiſ cant increase in the duration of action of the local anaesthesia. Further supported by a less VAS score and a less number of the analgesics in the ſ rst post-operative day, it is due to the long duration of action of lidocaine ſ rst, a few hour after TMS, in the presence of dexamethasone.
CONCLUSIONS
As the TMS in our setting is usually performed under local anesthesia, there is a convenience for both the surgeon and the patient in the use of submucosal CS. Technically, the submucosal route is easier to perform, without any extra skill necessary for IV or IM, and is not dependent on patient compliance and in without noticeable systemic side effects. Our study shows that dexamethasone prolongs the duration of action of lidocaine nerve block and successfully reduces the post-operative sequelae after TMS. Hence, 8 mg dexamethasone can be used in routine TMS to improve the post-operative quality of life of the patient, but it is not advocated in simple dental extraction.
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